Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy

BJU Int. 2003 Nov;92(7):824. doi: 10.1046/j.1464-410x.2003.t01-4-04488.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Disease-Free Survival
  • Humans
  • Male
  • Prostate-Specific Antigen / blood*
  • Prostatectomy / methods*
  • Prostatic Neoplasms / surgery*

Substances

  • Prostate-Specific Antigen